-transparent.png){kind=logo}
An immunochemical characterization of carcinoembryonic antigen (CEA) and NCA (non-specific cross-reacting antigen) was performed. Positive reactions of CEA and NCA (Mr 60 000) with some antibodies to alpha 1-acid glycoprotein (AG) were observed. Thus, both antigens may contain immune determinants in common with alpha 1-acid glycoprotein. CEA showed positive reactivity with anti-NCA. NCA showed positive reactivity with either polyclonal or monoclonal antibodies to CEA, but negative reactivity with auto-antibodies to CEA. 125I-Tetracosapeptide (synthetic peptide-24 corresponding to the amino terminal sequence of CEA) failed to react with any antisera against CEA, NCA and AG. 125I-AG also showed no immuno-reaction with any antibody against CEA, NCA and tetracosapeptide. These results suggest that some monoclonal antibodies to CEA are directed against a common antigenic determinant of both CEA and NCA in addition to AG and tetracosapeptide, and that the auto-antibody to CEA is directed against a unique immune determinant which is not common to NCA. Thus, CEA appears to contain a unique determinant not found in NCA. Similarities in the composition of both amino acids and carbohydrates of CEA and NCA suggest that CEA is 'big-big' AG and NCA is 'big' AG.
Y Ochi, and
Y Ura, and
M Hamazu, and
Y Fujiyama, and
Y Kajita, and
M Ishida, and
T Miyazaki, and
K Tamura
July 1982,
Clinica chimica acta; international journal of clinical chemistry,
Y Ochi, and
Y Ura, and
M Hamazu, and
Y Fujiyama, and
Y Kajita, and
M Ishida, and
T Miyazaki, and
K Tamura
July 1980,
European journal of cancer,
Y Ochi, and
Y Ura, and
M Hamazu, and
Y Fujiyama, and
Y Kajita, and
M Ishida, and
T Miyazaki, and
K Tamura
November 1983,
Cancer,
Y Ochi, and
Y Ura, and
M Hamazu, and
Y Fujiyama, and
Y Kajita, and
M Ishida, and
T Miyazaki, and
K Tamura
June 1979,
International journal of cancer,
Y Ochi, and
Y Ura, and
M Hamazu, and
Y Fujiyama, and
Y Kajita, and
M Ishida, and
T Miyazaki, and
K Tamura
October 1989,
Biochemical and biophysical research communications,
Y Ochi, and
Y Ura, and
M Hamazu, and
Y Fujiyama, and
Y Kajita, and
M Ishida, and
T Miyazaki, and
K Tamura
May 1975,
British journal of cancer,
Y Ochi, and
Y Ura, and
M Hamazu, and
Y Fujiyama, and
Y Kajita, and
M Ishida, and
T Miyazaki, and
K Tamura
March 1985,
American journal of clinical pathology,
Y Ochi, and
Y Ura, and
M Hamazu, and
Y Fujiyama, and
Y Kajita, and
M Ishida, and
T Miyazaki, and
K Tamura
July 1983,
Molecular immunology,
Y Ochi, and
Y Ura, and
M Hamazu, and
Y Fujiyama, and
Y Kajita, and
M Ishida, and
T Miyazaki, and
K Tamura
August 1986,
Journal of immunology (Baltimore, Md. : 1950),
Y Ochi, and
Y Ura, and
M Hamazu, and
Y Fujiyama, and
Y Kajita, and
M Ishida, and
T Miyazaki, and
K Tamura
May 1989,
Annals of human genetics,
